Bruker Corporation (BRKR) Stock
Healthcare · Medical Devices · Member of Other US Stocks
Bruker Corporation (BRKR) closed at USD 56.54 on 2026-10-15, a change of +50.4 % over the past year, with a market capitalization of USD 8.35B.
Bruker Corporation recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-15 | 56.54 |
| 2026-10-14 | 55.60 |
| 2026-10-13 | 56.19 |
| 2026-10-12 | 56.25 |
| 2026-10-09 | 58.84 |
| 2026-10-08 | 57.92 |
| 2026-10-07 | 59.72 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Bruker Corporation key figures
- Previous close
- USD 56.54 (2026-10-15)
- 1-year change
- +50.4 %
- Market cap
- USD 8.35B
- Enterprise value
- USD 10.07B
- P/E ratio (trailing)
- -78.29
- P/E ratio (forward)
- 22.90
- EPS (trailing)
- -0.70
- EPS (forward)
- 2.39
- PEG ratio
- 1.52
- Price to book
- 3.51
- Revenue growth
- 5.2 %
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.20
- Short ratio
- 5.52
- Employees
- 11,085
- Analyst consensus (third-party)
- buy
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Bruker Corporation
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Bruker Corporation and compare it with other stocks.
Analyze BRKRAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Bruker Corporation shares.